Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 712

1.

Antiplatelet therapy in populations at high risk of atherothrombosis.

Faxon DP, Nesto RW.

J Natl Med Assoc. 2006 May;98(5):711-21. Review.

PMID:
16749646
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

Bhatt DL, Topol EJ; Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee.

Am Heart J. 2004 Aug;148(2):263-8.

PMID:
15308995
[PubMed - indexed for MEDLINE]
3.

From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.

Hacke W.

Cerebrovasc Dis. 2002;13 Suppl 1:22-6. Review.

PMID:
11803184
[PubMed - indexed for MEDLINE]
5.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

PMID:
15461876
[PubMed - indexed for MEDLINE]
Free Article
6.

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

Zusman RM, Chesebro JH, Comerota A, Hartmann JR, Massin EK, Raps E, Wolf PA.

Clin Cardiol. 1999 Sep;22(9):559-73. Review.

PMID:
10486695
[PubMed - indexed for MEDLINE]
7.

Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.

Montalescot G.

Clin Cardiol. 2000 Nov;23 Suppl 6:VI-18-22. Review.

PMID:
11129682
[PubMed - indexed for MEDLINE]
8.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
[PubMed - indexed for MEDLINE]
9.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315
[PubMed - indexed for MEDLINE]
10.

Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.

Jamieson DG, Parekh A, Ezekowitz MD.

J Cardiovasc Pharmacol Ther. 2005 Sep;10(3):153-61. Review.

PMID:
16211203
[PubMed - indexed for MEDLINE]
11.

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness.

Ho WK, Hankey GJ, Eikelboom JW.

Expert Opin Pharmacother. 2004 Mar;5(3):493-503. Review.

PMID:
15013918
[PubMed - indexed for MEDLINE]
12.

[The CHARISMA study: in search of the best antiplatelet strategy for cardiovascular prevention].

Scheen AJ.

Rev Med Liege. 2006 Sep;61(9):656-61. French.

PMID:
17112168
[PubMed - indexed for MEDLINE]
13.

Aspirin and clopidogrel: a sweeping combination in cardiology.

Manolis AS, Tzeis S, Andrikopoulos G, Koulouris S, Melita H.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):203-19. Review.

PMID:
15974885
[PubMed - indexed for MEDLINE]
14.

Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?

Bakhru MR, Bhatt DL.

Cleve Clin J Med. 2008 Apr;75(4):289-95. Review.

PMID:
18491435
[PubMed - indexed for MEDLINE]
Free Article
15.

Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.

Reaume KT, Regal RE, Dorsch MP.

Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Review.

PMID:
18319394
[PubMed - indexed for MEDLINE]
16.

Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.

Mehta SR, Yusuf S.

J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):79S-88S. Review.

PMID:
12644345
[PubMed - indexed for MEDLINE]
17.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
[PubMed - indexed for MEDLINE]
18.

Identification of and management approaches for the high-risk patient.

Bhatt DL.

Am J Cardiol. 2006 Dec 18;98(12A):22Q-29Q. Epub 2006 Oct 23. Review.

PMID:
17169626
[PubMed - indexed for MEDLINE]
19.

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.

Mehta SR, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators.

Eur Heart J. 2000 Dec;21(24):2033-41.

PMID:
11102254
[PubMed - indexed for MEDLINE]
Free Article
20.

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators.

N Engl J Med. 2006 Apr 20;354(16):1706-17. Epub 2006 Mar 12.

PMID:
16531616
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk